Calidi Biotherapeutics, Inc. (CLDI) stock
Close on Nov 13, 2026Market cap $1.61MP/E –Yield –
Calidi Biotherapeutics statistics
59 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 26, 2027 (estimated, during market hours)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 0.99
- 2.22
Share statisticsIndustry
- Shares Change (YoY)
- 622.2%
- 10.8%
- Shares Change (QoQ)
- 38.5%
- 0.50%
- Float
- 1M
- 49M
- Shares Held by Insiders
- 58.4%
- 11.7%
Short sellingIndustry
- Short Interest
- 135,691
- –
- Short Interest Change
- -17.4%
- -0.80%
- Days to Cover
- 2.48
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $24.96
- –
- 52-Week Low
- $0.62
- –
- 20-Day Moving Average
- $0.69
- –
- 50-Day Moving Average
- $0.94
- –
- 200-Day Moving Average
- $3.65
- –
- Average True Range (14)
- $0.07
- –
- Price Change (1 Week)
- -11.2%
- -1.15%
- Price Change (1 Month)
- -28.5%
- -4.87%
- Price Change (3 Months)
- -54.3%
- -21.0%
- Price Change (6 Months)
- -79.1%
- -20.6%
- Price Change (YTD)
- -96.7%
- -23.6%
- Price Change (1 Year)
- -97.4%
- -22.4%
- Price Change (3 Years)
- -100.0%
- -29.5%
- Price Change (5 Years)
- -100.0%
- -77.9%
- Average Volume (10 Days)
- 35,320
- –
- Average Volume (20 Days)
- 46,015
- –
- Average Volume (90 Days)
- 197,237
- –
- Relative Volume
- 0.14
- 0.70
- Relative Strength Index (14)
- 32.3
- 43.4
- Volatility (1 Year)
- 93.9%
- 80.1%
- Beta (5 Years)
- 0.50
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -373.6%
- -49.9%
- Return on Assets (ROA)
- -163.4%
- -40.6%
- Return on Capital Employed (ROCE)
- -954.3%
- -37.9%
Financial positionIndustry
- Current Ratio
- 1.27
- 3.30
- Quick Ratio
- 1.06
- 2.39
- Debt / Equity
- 0.41
- 0.49
- Interest Coverage
- -252.18
- -6.35
EfficiencyIndustry
- WACC
- 7.74%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$15.96M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $3.28M
- $17.76M
- Net Cash Per Share
- $1.27
- $0.80
- Equity (Book Value)
- $1.63M
- $53.89M
- Book Value Per Share
- $0.63
- $1.50
- Tangible Book Value
- $1.63M
- $27.13M
- Working Capital
- $1.01M
- $79.99M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -993.7%
- -21.8%
Taxes and interestIndustry
- Interest Expense
- $68.00K
- $2.90M
- Income Tax
- $16.00K
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- -48.70
- 0.23
- Piotroski F-Score
- 3
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | CLDI | S&P 500 | Difference | CLDI per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -30.9% | -3.0% | −27.9 pts | ||
| 3 months | -59.6% | -2.8% | −56.8 pts | ||
| Year to date | -96.7% | +11.5% | −108.2 pts | ||
| 1 year | -97.4% | +13.5% | −110.9 pts | ||
| 3 years | -100.0% | +77.7% | −177.7 pts | -94.7% | +21.1% |
| 5 years | -100.0% | +72.6% | −172.6 pts | -87.3% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M CLDI shares were sold short on Oct 30, 2026, down 17.4% from the previous report. At recent volumes it would take 2.5 days to buy them back. Over the last 20 sessions, 25.7% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 135,691 | -17.4% | 54,754 | 2.5 |
| Oct 15, 2026 | 164,295 | -29.6% | 39,227 | 4.2 |
| Sep 30, 2026 | 233,287 | +2.4% | 380,101 | 1.0 |
| Sep 15, 2026 | 227,775 | -1.4% | 36,572 | 6.2 |
| Aug 31, 2026 | 231,117 | -26.2% | 98,100 | 2.4 |
| Aug 14, 2026 | 313,261 | +35.4% | 201,576 | 1.6 |
| Jul 31, 2026 | 231,318 | -93.2% | 665,888 | 1.0 |
| Jul 15, 2026 | 3,421,439 | -20.0% | 2,133,866 | 1.6 |
| Jun 30, 2026 | 4,276,018 | +251.3% | 6,265,161 | 1.0 |
| Jun 15, 2026 | 1,217,102 | +63.6% | 4,877,889 | 1.0 |
| May 29, 2026 | 743,922 | +10.9% | 2,295,426 | 1.0 |
| May 15, 2026 | 670,614 | -77.9% | 2,410,748 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?